🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the present study is to evaluate the best regimen for inflixima...
Status
Terminated
Location
The E. Wolfson.Medical Center
Start Date
2013-02
Trial ID
NCT01802593
Treatments Being Tested
A single center, single dose, open-label, randomized, two period crossover ...
Status
Completed
Location
Nova Laboratories Limited
Start Date
2019-04-11
Trial ID
NCT03930264
Treatments Being Tested
A growing number of patients with Crohn's disease are treated with immunosu...
Status
Completed
Location
Yonsei University: Wonju Christian Hospital
Start Date
2011-12
Trial ID
NCT01505855
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2003-11
Trial ID
NCT00059839
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
This study is a 52-week, randomized, open, active-controlled trial of patie...
Status
Unknown
Location
RenJi Hospital
Start Date
2017-09-07
Trial ID
NCT02936375
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested